Symbotic Inc vs Health Care Select Sector SPDR Fund — how do they compare? Symbotic Inc trades at $42.3 (market cap $5.62B), while Health Care Select Sector SPDR Fund trades at $168.14 (market cap $43.11B). The key difference: Health Care Select Sector SPDR Fund is far larger — about 7.7× Symbotic Inc's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Symbotic Inc for 23 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| SYM | XLV | |
|---|---|---|
Market Cap | $5.62B | $43.11B |
Volume | 1,339,679 | 8,870,090 |
Sector | Industrials | — |
52-Week High | $87.30 | $175.68 |
52-Week Low | $38.22 | $141.95 |
Typical Hold Time | 23 Days | 100 Days |
Enterprise Value | $3.88B | — |
Signals from Pluang's Aura AI — not financial advice
SYM trades at $43.31, down 1.9% on the day, with a bullish technical signal supported by moving averages. The company shows strong revenue growth potential with a $22.5 billion backlog but faces profitability challenges with negative net income of -$16.94 million in 2025. Analyst consensus is positive with a $60.33 price target, though recent earnings misses and customer concentration risk remain concerns.
SYM presents a growth opportunity in warehouse automation with significant backlog and expanding market demand, but investors must weigh high valuation multiples against current profitability issues and execution risks. The stock's upside depends on successful margin expansion and diversification beyond its major customer relationship.
XLV trades at $168.81, up 1.03% with a bullish technical signal from moving averages. The healthcare ETF shows strength with 61 diversified holdings and a low 0.08% expense ratio. Recent news highlights its defensive characteristics during market volatility and potential benefits from rising interest rates. Technical indicators show support at $168 with resistance at $170, while oscillators remain neutral.
XLV offers defensive exposure to healthcare with cost efficiency, though concentration in S&P 500 stocks limits global diversification. Political uncertainty and sector-specific risks like FDA approvals present challenges, but the ETF's broad diversification and historical performance during rate hikes support a constructive outlook for long-term investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →